The cerebrospinal fluid Neutrophil gelatinase‐associated lipocalin (NGAL) concentration in Alzheimer’s Disease (AD)
Julia Doroszkiewicz, Agnieszka Kulczynska‐Przybik, Renata Borawska, Jan Mroczko, Agnieszka Slowik, Barbara Mroczko · 2025
Read The cerebrospinal fluid Neutrophil gelatinase‐associated lipocalin (NGAL) concentration in Alzheimer’s Disease (AD) by Julia Doroszkiewicz, Agnieszka Kulczynska‐Przybik, Renata Borawska, Jan Mroczko, Agnieszka Slowik, Barbara Mroczko (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11715242.txt.
Description
Julia Doroszkiewicz and co-authors gauged a protein called NGAL in the spinal fluid of patients. NGAL is short for neutrophil gelatinase-associated lipocalin, a protein tied to swelling in the brain. Traces of it have been found in the brains of people with Alzheimer's disease. The team asked if its level in fluid could help spot the disease.
They drew fluid from twenty patients with the disease and twenty adults with no dementia. A lab test gauged NGAL next to the standard fluid signs of the disease. Levels ran much higher in the patient group than in the control group. Higher levels also went with higher tau signs and a lower amyloid score. The authors read this as a sign that NGAL plays a part in the disease. They call for a test of the mark in a much larger group before any clinic use.
Catalog record
| CREATOR | Julia Doroszkiewicz, Agnieszka Kulczynska‐Przybik, Renata Borawska, Jan Mroczko, Agnieszka Slowik, Barbara Mroczko |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |